Skip to content

Clinical trials

Completed Dyslipidemias trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Status: Completed Country / region: Brazil Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20069
20072
20081
20091
20121
20132
20161
20172
20183
20193
20214
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
Hospital de Clinicas de Porto Alegre3
Amgen2
EMS2
Hospital Israelita Albert Einstein2
Kastle Therapeutics, LLC2
National Institute of Cardiology, Laranjeiras, Brazil2
Sanofi2
Universidade Federal do Rio de Janeiro2
Ache Laboratorios Farmaceuticos S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias36
Diabetes Mellitus, Type 210
Diabetes Mellitus9
Glucose Metabolism Disorders7
Hypertension5
Cardiovascular Diseases4
Hypercholesterolemia4
Hyperlipidemias4
Lipid Metabolism Disorders3
Obesity3

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.